Used in pharmaceutical research as a potent and selective inhibitor of specific kinase enzymes involved in inflammatory and oncogenic signaling pathways. Shows promising activity in preclinical studies for the treatment of autoimmune disorders and certain cancers, particularly due to its ability to modulate immune cell activation and proliferation. Its structural configuration allows for high binding affinity and improved metabolic stability, making it a candidate for oral drug development. Currently under investigation for optimizing dosing regimens and evaluating long-term safety in animal models.